Antibacterial Activity of Marine Fungi Against Veterinary Based Clinical Pathogens

P. Sudhakar,G. Anuhya,C. Uma,I. Lakshmi,C. Rao,V. Jyostna,G. Samuel,B. Bodaiah
DOI: https://doi.org/10.32628/IJSRST1845141
2018-03-20
Abstract:Marine fungal metabolites are bioactive compounds develop and inhibit the growth of microbial and clinical pathogens. So, the Present study was focussed on potentiality of gaps-1 and gaps-2 against standard antibiotic tetracycline by their bioactivity to fetch out the veterinary medicine that are used by the bovine and poultry farmers. Bioactive metabolites were extracted from marine fungal isolates (GAPS-1 and GAPS-2) through solvent extraction. Potency of metabolite was determined by antibacterial assay and MIC (minimum inhibitory concentration) against Clinical pathogens like Escherichia coli, Klebsiella, Pasteurella multocida using standard antibiotic tetracycline as a standard. Fungal extracts of (GAPS-1 and GAPS-2) are effectively extracted in Ethyl acetate, when compared to chloroform, hexane and petroleum either respectively, both extracts had showed a prominence antibacterial activity on all test organisms and MIC of both extracts starts from 500μg where as standard antibiotic tetracycline starts from 250μg. Since both fungal isolates revealed significant effect on clinical pathogens indicating the potentiality of marine environment in producing alternatives of chemically synthesizing standard antibiotics.
Medicine,Biology,Environmental Science
What problem does this paper attempt to address?